Chernichenko, O.A.; Sakalo, V.S.; Yakovlev, P.G.; Sakalo, A.V.; Zhylchuk, Y.V.; Zsolt, A.
(Experimental Oncology, 2014)
The androgen-suppressive therapy (AST) in patients with prostate cancer (PC) may dramatically affect the bone mineral density (BMD), which puts patients at risk of severe adverse effects, such as weight-bearing bone ...